raps.org

GYPbQ TIL The US Court of Appeals for the First Circuit finds Sanofi improperly listed insulin device patent in FDA’s Orange Book
wPV6 TIL the company that makes coral snake antivenom in the USA decided it was unprofitable and stopped producing it in 2003. The USA’s stock of coral snake antivenom expired in 2008 but the FDA has extended the date ever since to keep what is left available to the public.
15gd TIL that 15% of the US population believes that the pharmaceutical industry invents diseases so they can sell a cure.